AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Novel Two-Step Dosing Induction Strategy (The Propofol Challenge Test) to Minimize Propofol Injection Pain

RecruitingPhase 4Ages 18 Years - anyAllErasme University Hospital
💬

In plain words

What the trial is, and whether it could suit you

Propofol is the most widely used intravenous hypnotic agent for the induction of general anesthesia owing to its rapid onset and short duration of action. Despite its favorable pharmacokinetics and widespread use, a notable drawback persists: the incidence of pain on injection. Statistics on the matter are widely variable, but some estimates indicate that the incidence of pain with propofol injection is around 70%1. To date, no studies have systematically evaluated whether dividing the induction dose of propofol-starting with a small sub-induction bolus (e.g., 20 mg) followed by the remainder-can reduce pain perception. We hypothesize that a two-step administration of propofol-consisting of a small initial dose followed by the remaining dose-may serve as a nociceptive preconditioning stimulus and reduce postoperative patient-recalled injection pain compared to standard single-bolus adm

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Adults ≥18 years old. * Undergoing non cardiac surgery under general anesthesia. * Receiving propofol for induction. * No midazolam premedication * 20g IV Catheter below the antecubital fossa used for induction of anesthesia Exclusion Criteria: * Emergency surgery. * Inability to communicate (language or cognitive impairment). * Pre-induction IV analgesia administration or patients under preoperatively * Patient with dementia, Alzheimer or other uncontrolled psychiatric diseases that would impact their ability to willingly participate
💊

What it tests

  • Bolus injection
  • Fractionned onjection
📍

Where

1 site
Hôpital Universitaire de Bruxelles - Hôpital erasme
Brussels, Belgium
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy